Hansoh Pharma (03692) completed the issuance of HK$4.68 billion interest-free convertible bonds.

20:14 03/02/2026

Hanson Pharmaceutical (03692) announced that it proposes to issue zero coupon convertible bonds of HKD 4.68 billion due in 2033. All the conditions precedent of the subscription agreement for the issuance of bonds have been fulfilled, and the issuance of bonds was successfully implemented on February 3, 2026.

Hansoh Pharma (03692) announced the proposal to issue 4.68 billion Hong Kong dollars of zero-coupon convertible bonds maturing in 2033. All the conditions for the issuance of the bonds as stated in the subscription agreement have been met, and the bonds were successfully issued on February 3, 2026. The company has been approved for listing and trading of the convertible shares on the Hong Kong Stock Exchange. The bonds are expected to be listed and traded on the Vienna MTF, a securities exchange in Vienna, on or around February 4, 2026.

US Stock Market Move | Q4 performance greatly exceeds expectations, Palantir (PLTR.US) surges nearly 12% in pre-market trading.

WANGUO GOLD GP(03939): Wang Lixin has been appointed as an executive director.

YIDU TECH(02158): The Hong Kong Stock Exchange confirms that Feng Xiaoying meets the qualifications of company secretary.

US Stock Market Move | Q4 performance greatly exceeds expectations, Palantir (PLTR.US) surges nearly 12% in pre-market trading.

WANGUO GOLD GP(03939): Wang Lixin has been appointed as an executive director.

YIDU TECH(02158): The Hong Kong Stock Exchange confirms that Feng Xiaoying meets the qualifications of company secretary.